NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

Urolithin A, a natural postbiotic known to trigger mitophagy, rejuvenated key immune cell functions in healthy middle-aged ...

Adding the PCSK9 inhibitor evolocumab to standard lipid-lowering therapy significantly reduced first major cardiovascular ...

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy ...

CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise ...

Researchers from Mass General Brigham have found that olezarsen—a drug designed to lower triglyceride levels—can also decrease the risk of acute pancreatitis, a potential complication in patients with ...

Alixorexton, an investigational, oral, selective orexin 2 receptor agonist, demonstrated meaningful improvements across the trial’s dual primary endpoints of change from baseline in Maintenance of ...

Popular gut microbiome treatments for autism lack scientific support. Studies show probiotics likely aren't an effective ...

Amylin receptor agonists are gaining attention as a new class of anti-obesity drugs. Eloralintide, a novel and selective long ...

Use of rifaximin soluble solid dispersion tablets for up to 24 weeks did not increase infection-related adverse events among patients with cirrhosis, according to data presented at ACG Annual ...